task
stringlengths 12
101
| input
stringlengths 0
5.49k
| output
stringlengths 1
7.33k
| options
sequence | pageTitle
stringlengths 0
712
| outputColName
stringlengths 1
846
| url
stringlengths 17
295
| wdcFile
stringlengths 68
75
|
|---|---|---|---|---|---|---|---|
97b72e3c_Oil___Marine___Gannon_Oils_Ltd__Features | Protects wear surfaces from water and acidic corrosion [Features] | Outstanding rust and corrosion properties | [] | Mobilgard M430 | Trunk Piston Engine Oils | Marine Engine Oil | Marine | Gannon Oils Ltd | Features | http://www.gannonoils.co.uk/Marine/Marine_Engine_Oil/Trunk_Piston_Engine_Oils/Mobilgard_M430.html | 39/1438043062723.96_20150728002422-00244-ip-10-236-191-2_455018263_2.json |
97b72e3c_Oil___Marine___Gannon_Oils_Ltd__Features | Reduced sludge formation, longer oil life, cleaner engines [Features] | High Residual Fuel Compatibility | [] | Mobilgard M430 | Trunk Piston Engine Oils | Marine Engine Oil | Marine | Gannon Oils Ltd | Features | http://www.gannonoils.co.uk/Marine/Marine_Engine_Oil/Trunk_Piston_Engine_Oils/Mobilgard_M430.html | 39/1438043062723.96_20150728002422-00244-ip-10-236-191-2_455018263_2.json |
97b72e3c_Oil___Marine___Gannon_Oils_Ltd__Features | Reduced lubricant consumption [Features] | Low volatility base stocks | [] | Mobilgard M430 | Trunk Piston Engine Oils | Marine Engine Oil | Marine | Gannon Oils Ltd | Features | http://www.gannonoils.co.uk/Marine/Marine_Engine_Oil/Trunk_Piston_Engine_Oils/Mobilgard_M430.html | 39/1438043062723.96_20150728002422-00244-ip-10-236-191-2_455018263_2.json |
97b72e3c_Oil___Marine___Gannon_Oils_Ltd__Features | Combats fuel/combustion related corrosion and deposits [Features] | Excellent TBN Reserve and Retention | [] | Mobilgard M430 | Trunk Piston Engine Oils | Marine Engine Oil | Marine | Gannon Oils Ltd | Features | http://www.gannonoils.co.uk/Marine/Marine_Engine_Oil/Trunk_Piston_Engine_Oils/Mobilgard_M430.html | 39/1438043062723.96_20150728002422-00244-ip-10-236-191-2_455018263_2.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] CORROSITEX Skin Corrosivity test [Replaces] | Dermal corrosion tests in rabbits | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] In vitro reconstructed human epidermis test methods for skin corrosivity (i.e. EpiSkin, EpiDerm, SkinEthic, and EpiCS) [Replaces] | Dermal corrosion and dermal irritation tests in rabbits | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] Rat TER Skin Corrosivity test [Replaces] | Dermal corrosion tests in rabbits | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] 3T3 NRU Phototoxicity Test [Replaces] | Phototoxicity tests in rats and rabbits | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] Bovine corneal opacity and permeability test methods [Replaces] | Ocular toxicity tests in rabbits | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] Isolated chicken eye test method [Replaces] | Ocular toxicity tests in rabbits | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] Flourescein leakage test method [Replaces] | Ocular toxicity tests in rabbits | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] In vitro cytotoxicity test methods [Replaces] | Acute toxicity tests in rabbits and rodents | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] Stably transfected human estrogen receptor-a transcriptional activation assay [Replaces] | Endocrine disrupter tests in mice, rats, fish, and amphibians | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] BG1Luc Estrogen reception transactivation test method [Replaces] | Endocrine disrupter tests in mice, rats, fish, and amphibians | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
e26332ae_Act___Animal_Welfare_Institute__Replaces | [Method] In vitro micronucleus test [Replaces] | Genetic toxicity tests in mice and rats | [] | The Humane Cosmetics Act | Animal Welfare Institute | Replaces | https://awionline.org/content/humane-cosmetics-act | 39/1438042989126.22_20150728002309-00273-ip-10-236-191-2_869608136_1.json |
ca6bc014_4___ornithine_aminotransferase__ID | [Resource] InterPro [Description] Aminotransferase class-III [ID] | IPR005814 | [
[
"I",
"P",
"R",
"0",
"0",
"5",
"8",
"1",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"0",
"1",
"6",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"1"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"2"
],
[
"P",
"R",
":",
"0",
"0",
"0",
"0",
"1",
"1",
"5",
"7",
"8"
]
] | Oat MGI Mouse Gene Detail - MGI:97394 - ornithine aminotransferase | ID | http://www.informatics.jax.org/marker/MGI:97394 | 39/1438042989126.22_20150728002309-00165-ip-10-236-191-2_521647658_8.json |
ca6bc014_4___ornithine_aminotransferase__ID | [Resource] InterPro [Description] Ornithine aminotransferase [ID] | IPR010164 | [
[
"I",
"P",
"R",
"0",
"0",
"5",
"8",
"1",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"0",
"1",
"6",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"1"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"2"
],
[
"P",
"R",
":",
"0",
"0",
"0",
"0",
"1",
"1",
"5",
"7",
"8"
]
] | Oat MGI Mouse Gene Detail - MGI:97394 - ornithine aminotransferase | ID | http://www.informatics.jax.org/marker/MGI:97394 | 39/1438042989126.22_20150728002309-00165-ip-10-236-191-2_521647658_8.json |
ca6bc014_4___ornithine_aminotransferase__ID | [Resource] InterPro [Description] Pyridoxal phosphate-dependent transferase [ID] | IPR015424 | [
[
"I",
"P",
"R",
"0",
"0",
"5",
"8",
"1",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"0",
"1",
"6",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"1"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"2"
],
[
"P",
"R",
":",
"0",
"0",
"0",
"0",
"1",
"1",
"5",
"7",
"8"
]
] | Oat MGI Mouse Gene Detail - MGI:97394 - ornithine aminotransferase | ID | http://www.informatics.jax.org/marker/MGI:97394 | 39/1438042989126.22_20150728002309-00165-ip-10-236-191-2_521647658_8.json |
ca6bc014_4___ornithine_aminotransferase__ID | [Resource] InterPro [Description] Pyridoxal phosphate-dependent transferase, major region, subdomain 1 [ID] | IPR015421 | [
[
"I",
"P",
"R",
"0",
"0",
"5",
"8",
"1",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"0",
"1",
"6",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"1"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"2"
],
[
"P",
"R",
":",
"0",
"0",
"0",
"0",
"1",
"1",
"5",
"7",
"8"
]
] | Oat MGI Mouse Gene Detail - MGI:97394 - ornithine aminotransferase | ID | http://www.informatics.jax.org/marker/MGI:97394 | 39/1438042989126.22_20150728002309-00165-ip-10-236-191-2_521647658_8.json |
ca6bc014_4___ornithine_aminotransferase__ID | [Resource] InterPro [Description] Pyridoxal phosphate-dependent transferase, major region, subdomain 2 [ID] | IPR015422 | [
[
"I",
"P",
"R",
"0",
"0",
"5",
"8",
"1",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"0",
"1",
"6",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"1"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"2"
],
[
"P",
"R",
":",
"0",
"0",
"0",
"0",
"1",
"1",
"5",
"7",
"8"
]
] | Oat MGI Mouse Gene Detail - MGI:97394 - ornithine aminotransferase | ID | http://www.informatics.jax.org/marker/MGI:97394 | 39/1438042989126.22_20150728002309-00165-ip-10-236-191-2_521647658_8.json |
ca6bc014_4___ornithine_aminotransferase__ID | [Resource] Protein Ontology [Description] ornithine aminotransferase, mitochondrial [ID] | PR:000011578 | [
[
"I",
"P",
"R",
"0",
"0",
"5",
"8",
"1",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"0",
"1",
"6",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"4"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"1"
],
[
"I",
"P",
"R",
"0",
"1",
"5",
"4",
"2",
"2"
],
[
"P",
"R",
":",
"0",
"0",
"0",
"0",
"1",
"1",
"5",
"7",
"8"
]
] | Oat MGI Mouse Gene Detail - MGI:97394 - ornithine aminotransferase | ID | http://www.informatics.jax.org/marker/MGI:97394 | 39/1438042989126.22_20150728002309-00165-ip-10-236-191-2_521647658_8.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 12.58 [KEGG pathway ID] map04350 [Description] | TGF-beta signaling pathway | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 11.61 [KEGG pathway ID] map05211 [Description] | Renal cell carcinoma | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 11.29 [KEGG pathway ID] map04710 [Description] | Circadian rhythm | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 9.35 [KEGG pathway ID] map04950 [Description] | Maturity onset diabetes of the young | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 4.84 [KEGG pathway ID] map05222 [Description] | Small cell lung cancer | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 4.84 [KEGG pathway ID] map04010 [Description] | MAPK signaling pathway | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 4.52 [KEGG pathway ID] map04330 [Description] | Notch signaling pathway | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 3.23 [KEGG pathway ID] map05219 [Description] | Bladder cancer | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 3.23 [KEGG pathway ID] map05216 [Description] | Thyroid cancer | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 3.23 [KEGG pathway ID] map05210 [Description] | Colorectal cancer | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 3.23 [KEGG pathway ID] map05213 [Description] | Endometrial cancer | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 3.23 [KEGG pathway ID] map04630 [Description] | Jak-STAT signaling pathway | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 3.23 [KEGG pathway ID] map05220 [Description] | Chronic myeloid leukemia | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 3.23 [KEGG pathway ID] map04012 [Description] | ErbB signaling pathway | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 3.23 [KEGG pathway ID] map04150 [Description] | mTOR signaling pathway | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 3.23 [KEGG pathway ID] map04310 [Description] | Wnt signaling pathway | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 3.23 [KEGG pathway ID] map05221 [Description] | Acute myeloid leukemia | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 2.90 [KEGG pathway ID] map04916 [Description] | Melanogenesis | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 2.90 [KEGG pathway ID] map05218 [Description] | Melanoma | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 1.94 [KEGG pathway ID] map04910 [Description] | Insulin signaling pathway | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
54f4c643_SMART__HLH_domain_annotation__Description | [% proteins involved] 0.97 [KEGG pathway ID] map04111 [Description] | Cell cycle - yeast | [] | SMART: HLH domain annotation | Description | http://smart.embl-heidelberg.de/smart/do_annotation.pl?DOMAIN=SM00353 | 39/1438042989126.22_20150728002309-00319-ip-10-236-191-2_219269794_4.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Iodine [Works well for] Unsaturated and aromatic compounds [Notes] Not permanent [Colors] | Brown spots | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Sulfuric acid [Works well for] General stain [Colors] | Brown or black spots | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Chromic acid [Works well for] For difficult to stain compounds [Colors] | Black spots | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] UV light [Works well for] Compounds with extended conjugation like aromatic compounds [Notes] Only visible under UV light [Colors] | Pink on light green background | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Ferric chloride [Works well for] Phenols [Colors] | Purple | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Ninhydrin [Works well for] Amino acids, amines [Colors] | Purple | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] 2,4-Dinitrophenylhydrazine [Works well for] Aldehydes, ketones [Notes] also called “DNP” [Colors] | Yellow/orange | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Vanillin [Works well for] Good general stain, very well for hydroxyl or carbonyl compounds [Colors] | Colors vary | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Potassium permanganate [Works well for] Works well for all compounds that can be oxidized [Notes] at r.t. for alkenes and alkynes upon heating for alcohols, amines, sulfides [Colors] | Yellow on purple Yellow or light brown on purple | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Bromocresol Green [Works well for] Carboxylic acids (pKa<5) [Colors] | Yellow spot on blue background | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Cerium molybdate (CAM, ‘Hanessian’s Stain’, Ceric staining) [Works well for] Good general stain, very well with polyhydroxylated and carbonyl compounds [Notes] Upon heating, very sensitive! [Colors] | Blue or green spot | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] p-Anisaldehyde [Works well for] Good general stain, particularly sensitive towards nucleophiles [Notes] Does not work with alkenes, alkynes or aromatic system unless functional groups are present [Colors] | Varying colors on light pink plate upon heating | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Phosphomolybdic acid (PMA) [Works well for] Very sensitive [Notes] Sensitivity can be enhanced by use of cobalt(II) chloride [Colors] | Dark green spot on light green plate | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Ehrlich’s Reagent (Dimethylaminobenzaldehyde) [Works well for] Indoles, amines [Colors] | Pink or red-violet | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
87a7a00e_Thin_Layer_Chromatography__Colors | [Reagent] Dragendorff-Munier Stain [Works well for] Amines even the ones that are low in reactivity [Colors] | Various colors | [] | Thin Layer Chromatography | Colors | http://www.chem.ucla.edu/~bacher/General/30BL/tips/TLC1.html | 39/1438042989126.22_20150728002309-00255-ip-10-236-191-2_364769781_1.json |
3010207c__Apricus_vs_Hills___ClearChain__Difference | [Hills] 10 Year [Apricus] 15 Year [Comment] If a company is willing to warrant a component for 5 years more, it is probably of higher quality Apricus is a global company with its own manufacturing operation. It exports to more than 30 countries and has offices in the US and Europe. Hills are simply buying OEM from a Chinese company with no direct control over the manufacturing, management, working conditions adherence to labor laws, pollution control or quality control. Apricus is fully a ISO9001:2008 certified operation and audited 3 -4 times a year from 3 party auditors from Australia, Germany, USA and China. Michael Humphreys, an Australian and the founder and CEO of Apricus is based full time in China managing the manufacturing facility. [Difference] | Heat Exchanger/Manifold Warranty | [] | Solar Hot Water - Evacuated Tubes - Apricus vs Hills - ClearChain | Difference | http://www.clearchain.com/blog/posts/solar-hot-water-evacuated-tubes-apricus-vs-hills | 39/1438042989126.22_20150728002309-00089-ip-10-236-191-2_372430035_1.json |
3010207c__Apricus_vs_Hills___ClearChain__Difference | [Hills] 64 Welds [Apricus] 6 Welds [Comment] Looking at both systems at a local ‘home expo’ this point is quite clear. Hills weld either side of the heat exchanger, Apricus only weld in a few places. The reason for this is probably due to the manifold setup. In the Apricus system the tube sits between two copper pipes. In the Hills there is weld joints either side of each collector. Personally, I believe less welds are stronger as you’ve not cut the original pipe in the first place! The Apricus header was specifically designed in that way to minimise welds which are potential failure points. The Apricus design is NOT less efficient in terms of heat transfer as we have a large head size which provides plenty of contact surface area. The heat pipe to header connection is not a bottle-neck to the system efficiency. [Difference] | Heat Exchanger Weld Joints | [] | Solar Hot Water - Evacuated Tubes - Apricus vs Hills - ClearChain | Difference | http://www.clearchain.com/blog/posts/solar-hot-water-evacuated-tubes-apricus-vs-hills | 39/1438042989126.22_20150728002309-00089-ip-10-236-191-2_372430035_1.json |
3010207c__Apricus_vs_Hills___ClearChain__Difference | [Hills] Supplied Caleffi 250 series [Apricus] Not Supplied [Comment] The steam relief valve was certainly an interesting point when comparing the differences. Hills use the Caleffi series valves (http://www.caleffi.com/en_IT/Technical_brochures/01133/01133.pdf). As noted in http://www.ata.org.au/forums/topic/apricus-or-hills-evacuated-tube-solar-hw-system these valves are designed to work with gycol and are not Potable (drinkable) water rated. The other interesting point is the the maximum temperature rating of the steam valve. Max temp is 180 degrees. Pure water turns to steam at 100 degrees. However it’s under pressure in the collector. Hence in order for steam to form it must be hotter than 100 degrees. On a hot day I can understand 180 degrees being met quite easily. This as indicated in the link can melt the steam valve. 1. They are not potable water rated. 2. They will fail due to scale buildup in the fine hole. 3. They will melt as the collector can reach 190oC 4. They will dump as much as 20L per day in steam, a fact that Apricus is raising with Australian Standards as system are not allowed to dump excessive volumes of water as a means of dissipating excess heat as outlined in AS2712:2007 “no-load” clause 7.4.3 and test methodology in Appendix F. [Difference] | Steam Relieve Valve | [] | Solar Hot Water - Evacuated Tubes - Apricus vs Hills - ClearChain | Difference | http://www.clearchain.com/blog/posts/solar-hot-water-evacuated-tubes-apricus-vs-hills | 39/1438042989126.22_20150728002309-00089-ip-10-236-191-2_372430035_1.json |
3010207c__Apricus_vs_Hills___ClearChain__Difference | [Hills] Plastic [Apricus] Rubber [Comment] I noticed this at a recent trade show. I do agree the plastic of the hill system will last longer. Though it’s not worth the significant cost difference. – You could even buy the boots from Hills and use them with Apricus! Apricus uses HTV Silicone Rubber because it is FAR SUPERIOR to any plastic in terms of UV resistance. It is a more expensive material choice than plastic, almost double the cost in fact. I would be interested to see a third party report showing that the plastic used by Hills will last the equivalent of 10 years UV exposure without significant loss of structural strength and function [Difference] | Rubber Holder vs Plastic Holder for evacuated tube end | [] | Solar Hot Water - Evacuated Tubes - Apricus vs Hills - ClearChain | Difference | http://www.clearchain.com/blog/posts/solar-hot-water-evacuated-tubes-apricus-vs-hills | 39/1438042989126.22_20150728002309-00089-ip-10-236-191-2_372430035_1.json |
3010207c__Apricus_vs_Hills___ClearChain__Difference | [Hills] Supplied [Apricus] Not Supplied [Comment] As discussed with a representative from Energymatters hills use a flow rate limiter where as Apricus do not. The rep. indicated the limiter was an important part of the system to make sure that the full efficiency was obtained from the collector. This didn’t sit well with me. Why when you have a pump moving water around would you want to slow it down? This puts pressure on the pump and makes it more likely to fail. Further investigation indicates it is due to the manifold design. The hills manifold is designed to hold 1.7l of water at a time, the apricus only 0.7l (30 tubes). Hence Hills needs the flow limiter as there’s more water to heat at any time. Apricus on the other hand is putting the same heat into less water, hence don’t need the limiter. 1. Until just the last couple of week the flow meter were NOT watermarked hence Apricus has not been allowing their use as we adhere strictly to the Australia Standards. Now they are finally certified Apricus is investigating making them a standard part of the system. 2. It should not be used to SLOW the water but rather to allow the actual flow rate to be observed and if too slow a faster speed on the pump can be chosen (if using a 3 speed pump), Apricus would not suggest restricting the flow rate by more than 25% otherwise it is effectively wasting electricity by artificially increasing the head pressure of the solar loop and forcing the pump to run longer each day. [Difference] | Flow Rate Limiter | [] | Solar Hot Water - Evacuated Tubes - Apricus vs Hills - ClearChain | Difference | http://www.clearchain.com/blog/posts/solar-hot-water-evacuated-tubes-apricus-vs-hills | 39/1438042989126.22_20150728002309-00089-ip-10-236-191-2_372430035_1.json |
3010207c__Apricus_vs_Hills___ClearChain__Difference | [Hills] ? [Apricus] Bianco three speed pump [Comment] Both pumps have a 1 year warranty. The Apricus pump is stainless steel, the Hills pump is unknown. The Apricus pump is a brass body pump, 3 speed. The Hills would also be brass or bronze but I think single speed. I don’t know of anybody using a SS body pump in the market. [Difference] | Circulating Pump | [] | Solar Hot Water - Evacuated Tubes - Apricus vs Hills - ClearChain | Difference | http://www.clearchain.com/blog/posts/solar-hot-water-evacuated-tubes-apricus-vs-hills | 39/1438042989126.22_20150728002309-00089-ip-10-236-191-2_372430035_1.json |
3010207c__Apricus_vs_Hills___ClearChain__Difference | [Hills] Stainless Steel [Apricus] Stainless Steel or Glass Lined [Comment] As from: http://www.ata.org.au/forums/topic/apricus-or-hills-evacuated-tube-solar-hw-system “3. The tanks used in the market by Apricus are Everlast (stainless steel) or Aquamax.. Hills use Everlast tanks too. They are both made in Australia. Stainless steel is a quality choice but more expensive. It is not suitable for all areas those as certain type of water, particularly bore, will quickly corrode stainless steel. The warranty policy of Everlast provides details of that. Vitreous enamel (aka glass lined) tanks don’t generally last as long as SS tanks as they are protected by a sacrificial magnesium anode which corrodes instead of the steel. The problem is that hardly anybody actually replaces the anode, which you should do once every 3-4 years (depending on water quality). If you DO replace the anode the tank could last 10+ years.“ [Difference] | Tank Choice | [] | Solar Hot Water - Evacuated Tubes - Apricus vs Hills - ClearChain | Difference | http://www.clearchain.com/blog/posts/solar-hot-water-evacuated-tubes-apricus-vs-hills | 39/1438042989126.22_20150728002309-00089-ip-10-236-191-2_372430035_1.json |
1ecbb13d_a_in_Hvar___Apartments_Komazin__Kitchen_and_cooking | [Tech] Free WiFi [Others] Air conditioning [Kitchen and cooking] | Cooker with oven | [
[
"C",
"o",
"o",
"k",
"e",
"r",
" ",
"w",
"i",
"t",
"h",
" ",
"o",
"v",
"e",
"n"
],
[
"C",
"o",
"o",
"k",
"i",
"n",
"g",
" ",
"e",
"q",
"u",
"i",
"p",
"m",
"e",
"n",
"t"
],
[
"F",
"r",
"i",
"d",
"g",
"e",
",",
" ",
"f",
"r",
"e",
"e",
"z",
"e",
"r"
],
[
"M",
"i",
"c",
"r",
"o",
"w",
"a",
"v",
"e"
],
[
"C",
"o",
"f",
"f",
"e",
"e",
" ",
"m",
"a",
"c",
"h",
"i",
"n",
"e"
],
[
"T",
"o",
"a",
"s",
"t",
"e",
"r"
]
] | Apartment Lavanda in Hvar | Apartments Komazin | Kitchen and cooking | http://croatia-hvar-apartments.com/apartment-lavanda/?show=gallery | 39/1438042989126.22_20150728002309-00309-ip-10-236-191-2_57480314_0.json |
1ecbb13d_a_in_Hvar___Apartments_Komazin__Kitchen_and_cooking | [Tech] Satellite flat screen TV [Others] Baby cot (on request) [Kitchen and cooking] | Cooking equipment | [
[
"C",
"o",
"o",
"k",
"e",
"r",
" ",
"w",
"i",
"t",
"h",
" ",
"o",
"v",
"e",
"n"
],
[
"C",
"o",
"o",
"k",
"i",
"n",
"g",
" ",
"e",
"q",
"u",
"i",
"p",
"m",
"e",
"n",
"t"
],
[
"F",
"r",
"i",
"d",
"g",
"e",
",",
" ",
"f",
"r",
"e",
"e",
"z",
"e",
"r"
],
[
"M",
"i",
"c",
"r",
"o",
"w",
"a",
"v",
"e"
],
[
"C",
"o",
"f",
"f",
"e",
"e",
" ",
"m",
"a",
"c",
"h",
"i",
"n",
"e"
],
[
"T",
"o",
"a",
"s",
"t",
"e",
"r"
]
] | Apartment Lavanda in Hvar | Apartments Komazin | Kitchen and cooking | http://croatia-hvar-apartments.com/apartment-lavanda/?show=gallery | 39/1438042989126.22_20150728002309-00309-ip-10-236-191-2_57480314_0.json |
1ecbb13d_a_in_Hvar___Apartments_Komazin__Kitchen_and_cooking | [Tech] DVD player [Others] Apartment heating, automatic boiler [Kitchen and cooking] | Fridge, freezer | [
[
"C",
"o",
"o",
"k",
"e",
"r",
" ",
"w",
"i",
"t",
"h",
" ",
"o",
"v",
"e",
"n"
],
[
"C",
"o",
"o",
"k",
"i",
"n",
"g",
" ",
"e",
"q",
"u",
"i",
"p",
"m",
"e",
"n",
"t"
],
[
"F",
"r",
"i",
"d",
"g",
"e",
",",
" ",
"f",
"r",
"e",
"e",
"z",
"e",
"r"
],
[
"M",
"i",
"c",
"r",
"o",
"w",
"a",
"v",
"e"
],
[
"C",
"o",
"f",
"f",
"e",
"e",
" ",
"m",
"a",
"c",
"h",
"i",
"n",
"e"
],
[
"T",
"o",
"a",
"s",
"t",
"e",
"r"
]
] | Apartment Lavanda in Hvar | Apartments Komazin | Kitchen and cooking | http://croatia-hvar-apartments.com/apartment-lavanda/?show=gallery | 39/1438042989126.22_20150728002309-00309-ip-10-236-191-2_57480314_0.json |
1ecbb13d_a_in_Hvar___Apartments_Komazin__Kitchen_and_cooking | [Tech] Radio [Others] Hair dryer and toiletries [Kitchen and cooking] | Microwave | [
[
"C",
"o",
"o",
"k",
"e",
"r",
" ",
"w",
"i",
"t",
"h",
" ",
"o",
"v",
"e",
"n"
],
[
"C",
"o",
"o",
"k",
"i",
"n",
"g",
" ",
"e",
"q",
"u",
"i",
"p",
"m",
"e",
"n",
"t"
],
[
"F",
"r",
"i",
"d",
"g",
"e",
",",
" ",
"f",
"r",
"e",
"e",
"z",
"e",
"r"
],
[
"M",
"i",
"c",
"r",
"o",
"w",
"a",
"v",
"e"
],
[
"C",
"o",
"f",
"f",
"e",
"e",
" ",
"m",
"a",
"c",
"h",
"i",
"n",
"e"
],
[
"T",
"o",
"a",
"s",
"t",
"e",
"r"
]
] | Apartment Lavanda in Hvar | Apartments Komazin | Kitchen and cooking | http://croatia-hvar-apartments.com/apartment-lavanda/?show=gallery | 39/1438042989126.22_20150728002309-00309-ip-10-236-191-2_57480314_0.json |
1ecbb13d_a_in_Hvar___Apartments_Komazin__Kitchen_and_cooking | [Others] Bed sheets, blankets and towels [Kitchen and cooking] | Coffee machine | [
[
"C",
"o",
"o",
"k",
"e",
"r",
" ",
"w",
"i",
"t",
"h",
" ",
"o",
"v",
"e",
"n"
],
[
"C",
"o",
"o",
"k",
"i",
"n",
"g",
" ",
"e",
"q",
"u",
"i",
"p",
"m",
"e",
"n",
"t"
],
[
"F",
"r",
"i",
"d",
"g",
"e",
",",
" ",
"f",
"r",
"e",
"e",
"z",
"e",
"r"
],
[
"M",
"i",
"c",
"r",
"o",
"w",
"a",
"v",
"e"
],
[
"C",
"o",
"f",
"f",
"e",
"e",
" ",
"m",
"a",
"c",
"h",
"i",
"n",
"e"
],
[
"T",
"o",
"a",
"s",
"t",
"e",
"r"
]
] | Apartment Lavanda in Hvar | Apartments Komazin | Kitchen and cooking | http://croatia-hvar-apartments.com/apartment-lavanda/?show=gallery | 39/1438042989126.22_20150728002309-00309-ip-10-236-191-2_57480314_0.json |
1ecbb13d_a_in_Hvar___Apartments_Komazin__Kitchen_and_cooking | [Others] Terrace furniture [Kitchen and cooking] | Toaster | [
[
"C",
"o",
"o",
"k",
"e",
"r",
" ",
"w",
"i",
"t",
"h",
" ",
"o",
"v",
"e",
"n"
],
[
"C",
"o",
"o",
"k",
"i",
"n",
"g",
" ",
"e",
"q",
"u",
"i",
"p",
"m",
"e",
"n",
"t"
],
[
"F",
"r",
"i",
"d",
"g",
"e",
",",
" ",
"f",
"r",
"e",
"e",
"z",
"e",
"r"
],
[
"M",
"i",
"c",
"r",
"o",
"w",
"a",
"v",
"e"
],
[
"C",
"o",
"f",
"f",
"e",
"e",
" ",
"m",
"a",
"c",
"h",
"i",
"n",
"e"
],
[
"T",
"o",
"a",
"s",
"t",
"e",
"r"
]
] | Apartment Lavanda in Hvar | Apartments Komazin | Kitchen and cooking | http://croatia-hvar-apartments.com/apartment-lavanda/?show=gallery | 39/1438042989126.22_20150728002309-00309-ip-10-236-191-2_57480314_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 1 [Running Time] 30 seconds [Web Preview*] Biesecker_01_low.mp4 (3.20 MB) [For Broadcast**] Biesecker_01_high.mp4 (47.64 MB) [Quotes (Text)] | I'm Les Biesecker. I'm a medical geneticist, senior investigator in the Genome Research Institute. My job being to figure out the molecular cause of disorders that affect children and adults, especially those that are inherited birth defects and other kinds of conditions. So we do both clinical research and molecular research. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 2 [Running Time] 32 seconds [Web Preview*] Biesecker_02_low.mp4 (3.79 MB) [For Broadcast**] Biesecker_02_high.mp4 (56.32 MB) [Quotes (Text)] | And so what Proteus syndrome is is parts of the body - you completely lose control of that regulatory growth - that regulated growth, and they grow much, much faster and in an uncoordinated fashion, either compared to the other limb, right versus left, or sometimes even within a single limb, a small part of that limb can grow out of proportion to the other parts. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 3 [Running Time] 28 seconds [Web Preview*] Biesecker_03_low.mp4 (3.91 MB) [For Broadcast**] Biesecker_03_high.mp4 (58.01 MB) [Quotes (Text)] | It's a devastating disorder, where patients - parts of patients' bodies grow out of control, and it has a high frequency of early mortality. So it is imperative that we find the cause for this disorder and figure out how to convert knowledge of that cause into an effective treatment. And the wonderful thing about this finding is that this is a pathway and a gene and a mutation that we know a lot about. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 4 [Running Time] 31 seconds [Web Preview*] Biesecker_04_low.mp4 (3.96 MB) [For Broadcast**] Biesecker_04_high.mp4 (58.77 MB) [Quotes (Text)] | And it's already a target of drug development because it is mutated in certain cancers. So we can piggyback off of the progress that's being made in this mutation in cancer, and try to apply that to patients with disease and this has allowed us to leap hugely forward in our understanding of the disorder and move toward a treatment that a few weeks ago, we had no idea how to tackle. So for the patients with the disorder, it's a huge advance. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 5 [Running Time] 33 seconds [Web Preview*] Biesecker_05_low.mp4 (4.28 MB) [For Broadcast**] Biesecker_05_high.mp4 (63.47 MB) [Quotes (Text)] | And most - and second, that people who have the condition have never been known to have effected offspring, and that we know of at least several - at least two pairs - of identical twins, monozygotic twins is the term, the technical term that we would use, who should have the same genomes. One of them has Proteus syndrome, and the other one doesn't. So that tells you that genetically, there's something very different about Proteus. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 6 [Running Time] 19 seconds [Web Preview*] Biesecker_06_low.mp4 (2.48 MB) [For Broadcast**] Biesecker_06_high.mp4 (36.99 MB) [Quotes (Text)] | So, we've been working on Proteus syndrome for 15 years. And we,ve been trying to crack this problem, using the most recent available technology that was available throughout that 15-year period. And technology has changed a lot in 15 years. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 7 [Running Time] 36 seconds [Web Preview*] Biesecker_07_low.mp4 (4.63 MB) [For Broadcast**] Biesecker_07_high.mp4 (68.82 MB) [Quotes (Text)] | And so we assume as next generation sequencing became available, we, together with the Proteus Syndrome Foundation, put together the resources to start whole genome or whole exome sequencing in Proteus syndrome patients, and the trick is, is that instead of comparing patients with the disease to patients without the disease, what we did is we compared the affected parts of the patient to the unaffected parts of the patient. Because if the patient is a mosaic, the mutation should be different in those two tissues, with and without. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 8 [Running Time] 36 seconds [Web Preview*] Biesecker_08_low.mp4 (4.67 MB) [For Broadcast**] Biesecker_08_high.mp4 (69.48 MB) [Quotes (Text)] | So the variation that we found in patients with Proteus syndrome is in a gene called AKT1, which is a gene that is an important part of a - it encodes for a protein that is an important part of a signaling pathway that is important in transmitting signals from growth factors through growth factor receptors into cells to turn cells on, turn cells off, turn genes on, turn genes off, make cells replicate, or regulate cell death. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 9 [Running Time] 16 seconds [Web Preview*] Biesecker_09_low.mp4 (2.06 MB) [For Broadcast**] Biesecker_09_high.mp4 (30.89 MB) [Quotes (Text)] | So it's a very specific mutation that we found in patients of Proteus syndrome. In fact, so far, 27 out of 29 patients who have the mutation, all 27 of those patients have exactly the same mutation. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 10 [Running Time] 25 seconds [Web Preview*] Biesecker_10_low.mp4 (3.22 MB) [For Broadcast**] Biesecker_10_high.mp4 (47.92 MB) [Quotes (Text)] | So in fact, the gene that is mutated in patients with Proteus syndrome was previously characterized exactly because it is mutated in a few percent of a number of human cancers. And those include cancers like breast cancer. About three or four percent of breast cancers have the exact same mutation in them that the patients with Proteus have. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 11 [Running Time] 19 seconds [Web Preview*] Biesecker_11_low.mp4 (2.46 MB) [For Broadcast**] Biesecker_11_high.mp4 (36.69 MB) [Quotes (Text)] | So it's extremely hard to know exactly what the frequency of a disease like Proteus syndrome is. It's - we know it's very, very rare. It's - there's probably fewer than a couple of hundred patients in the United States that have this disorder. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 12 [Running Time] 10 seconds [Web Preview*] Biesecker_12_low.mp4 (1.38 MB) [For Broadcast**] Biesecker_12_high.mp4 (20.42 MB) [Quotes (Text)] | So the one thing that we know about Proteus syndrome is that it never recurs, has never been seen in more than one individual in a single family. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 13 [Running Time] 15 seconds [Web Preview*] Biesecker_13_low.mp4 (1.99 MB [For Broadcast**] Biesecker_13_high.mp4 (29.44 MB) [Quotes (Text)] | Number one, so far, all the patients have exactly the same mutation, which means that there's only one change, one particular change in one base pair of the genome that could cause this disorder. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 14 [Running Time] 24 seconds [Web Preview*] Biesecker_14_low.mp4 (3.10 MB) [For Broadcast**] Biesecker_14_high.mp4 (46.29 MB) [Quotes (Text)] | So I think Proteus syndrome is a good example of why we should study rare disease, because this has allowed us to take a very rare disorder, which is - is a supremely important to understand for the patients who have it. But for the patients who don't have it, they should care about this, because this means that we can begin to think about a new class of genetic disease. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
a842709c__Footage_and_Video_Sound_Bites__Quotes__Text_ | [Clip #] 15 [Running Time] 20 seconds [Web Preview*] Biesecker_15_low.mp4 (2.63 MB) [For Broadcast**] Biesecker_15_high.mp4 (38.88 MB) [Quotes (Text)] | So the discovery of this AKT1 mutation in Proteus syndrome gives us a very clear pathway towards developing the clinical trials to test agents to control the disease. It will be extremely challenging, and I don't want to pretend that it's going to be simple or fast. | [] | Proteus Syndrome: B-Roll Video Footage and Video Sound Bites | Quotes (Text) | https://www.genome.gov/pfv.cfm?pageID=27544867 | 39/1438043062723.96_20150728002422-00229-ip-10-236-191-2_899472852_0.json |
0e2cf0ee___Article | [ID] 1 [Article] | Kanamycin | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 2 [Article] | Kava Kava, Piper methysticum | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 3 [Article] | Keeping Children Safe In and Around Cars | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 4 [Article] | Keeping Children Safe In and Around Water | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 5 [Article] | Keeping Poison Away from Children | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 6 [Article] | Kegel Exercises | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 7 [Article] | Ketamine | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 8 [Article] | Ketoconazole | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 9 [Article] | Ketone Bodies (Blood) | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 10 [Article] | Ketone Bodies (Urine) | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 11 [Article] | Ketoprofen | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 12 [Article] | Ketorolac | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 13 [Article] | Ketotifen | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 14 [Article] | Keys to Managing Stress | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
|
0e2cf0ee___Article | [ID] 15 [Article] | Kick Counts | [] | Article | http://www.fairview.org/healthlibrary/Search/index.htm?browse=K | 39/1438043062723.96_20150728002422-00154-ip-10-236-191-2_427358283_0.json |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.